m6A Target Gene Information
General Information of the m6A Target Gene (ID: M6ATAR00440)
Full List of m6A Methylation Regulator of This Target Gene and Corresponding Disease/Drug Response(s)
USP48
can be regulated by the following regulator(s), and cause disease/drug response(s). You can browse detail information of regulator(s) or disease/drug response(s).
Browse Regulator
Browse Disease
Methyltransferase-like 14 (METTL14) [WRITER]
Representative RNA-seq result indicating the expression of this target gene regulated by METTL14 | ||
Cell Line | mouse embryonic stem cells | Mus musculus |
Treatment: METTL14-/- ESCs
Control: Wild type ESCs
|
GSE145309 | |
Regulation |
|
logFC: -5.96E-01 p-value: 3.62E-16 |
More Results | Click to View More RNA-seq Results |
In total 1 item(s) under this regulator | ||||
Experiment 1 Reporting the m6A Methylation Regulator of This Target Gene | [1] | |||
Response Summary | Methyltransferase-like 14 (Mettl14)-induced m6A modification participated in the regulation of Ubiquitin carboxyl-terminal hydrolase 48 (USP48) in hepatocellular carcinoma by maintaining USP48 mRNA stability. This work uncovers the tumor-suppressive function of the Mettl14-USP48-SIRT6 axis via modulation of glycolysis, providing new insights into the critical roles of metabolic activities in HCC and identifying an attractive target for future treatment studies. | |||
Target Regulation | Up regulation | |||
Responsed Disease | Hepatocellular carcinoma | ICD-11: 2C12.02 | ||
Pathway Response | Ubiquitin mediated proteolysis | hsa04120 | ||
Glycolysis / Gluconeogenesis | hsa00010 | |||
Cell Process | Ubiquitination degradation | |||
Glycolysis | ||||
In-vitro Model | BEL-7404 | Endocervical adenocarcinoma | Homo sapiens | CVCL_6568 |
Huh-7 | Adult hepatocellular carcinoma | Homo sapiens | CVCL_0336 | |
SK-HEP-1 | Liver and intrahepatic bile duct epithelial neoplasm | Homo sapiens | CVCL_0525 | |
SK-HEP-1 | Liver and intrahepatic bile duct epithelial neoplasm | Homo sapiens | CVCL_0525 | |
In-vivo Model | Hepatocyte-specific knockout USP48 was obtained by crossing Alb-Cre mice with USP48flox/flox mice. | |||
Liver cancer [ICD-11: 2C12]
In total 1 item(s) under this disease | ||||
Experiment 1 Reporting the m6A-centered Disease Response | [1] | |||
Response Summary | Methyltransferase-like 14 (Mettl14)-induced m6A modification participated in the regulation of Ubiquitin carboxyl-terminal hydrolase 48 (USP48) in hepatocellular carcinoma by maintaining USP48 mRNA stability. This work uncovers the tumor-suppressive function of the Mettl14-USP48-SIRT6 axis via modulation of glycolysis, providing new insights into the critical roles of metabolic activities in HCC and identifying an attractive target for future treatment studies. | |||
Responsed Disease | Hepatocellular carcinoma [ICD-11: 2C12.02] | |||
Target Regulator | Methyltransferase-like 14 (METTL14) | WRITER | ||
Target Regulation | Up regulation | |||
Pathway Response | Ubiquitin mediated proteolysis | hsa04120 | ||
Glycolysis / Gluconeogenesis | hsa00010 | |||
Cell Process | Ubiquitination degradation | |||
Glycolysis | ||||
In-vitro Model | BEL-7404 | Endocervical adenocarcinoma | Homo sapiens | CVCL_6568 |
Huh-7 | Adult hepatocellular carcinoma | Homo sapiens | CVCL_0336 | |
SK-HEP-1 | Liver and intrahepatic bile duct epithelial neoplasm | Homo sapiens | CVCL_0525 | |
SK-HEP-1 | Liver and intrahepatic bile duct epithelial neoplasm | Homo sapiens | CVCL_0525 | |
In-vivo Model | Hepatocyte-specific knockout USP48 was obtained by crossing Alb-Cre mice with USP48flox/flox mice. | |||